Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitolisant in pediatric narcolepsy
NCT02611687Phase 3Completed
- Sponsor
- Bioprojet
- Start
- Jun 2016
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 3, randomised, double-blind trial in narcolepsy comparing Pitolisant with Placebo (2 arms). Primary endpoint: Ullanlinna Narcolepsy Scale at 8 weeks. Started Jun 2016; status: completed.
02
Drugs
pitolisant
03
Conditions
narcolepsy
Beyond the preview
Go deeper on NCT02611687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02611687.